rx 821002 has been researched along with rec 15-2739 in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (rec 15-2739) | Trials (rec 15-2739) | Recent Studies (post-2010) (rec 15-2739) |
---|---|---|---|---|---|
317 | 0 | 45 | 15 | 1 | 1 |
Protein | Taxonomy | rx 821002 (IC50) | rec 15-2739 (IC50) |
---|---|---|---|
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.024 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, DJ; D'Amico, J; Gorassini, MA; Murray, KC; Rank, MM; Stephens, MJ | 1 |
1 other study(ies) available for rx 821002 and rec 15-2739
Article | Year |
---|---|
Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Chromones; Clonidine; Excitatory Postsynaptic Potentials; Female; Idazoxan; Models, Animal; Motor Neurons; Norepinephrine; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Sensory Receptor Cells; Spasm; Spinal Cord Injuries; Synaptic Transmission | 2011 |